Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Clarivate Plc stock logo
CCC
Clarivate
$0.02
$29.06
$15.00
$33.55
$12.12M0.531.24 million shs19,871 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$3.18
+8.5%
$3.05
$2.58
$6.28
$212.07M1.0362,170 shs24,180 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Clarivate Plc stock logo
CCC
Clarivate
0.00%0.00%0.00%0.00%0.00%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
+8.53%+1.27%+10.42%-13.59%-32.20%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Clarivate Plc stock logo
CCC
Clarivate
1.1608 of 5 stars
0.00.00.03.80.00.82.5
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.1266 of 5 stars
3.45.00.00.01.10.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Clarivate Plc stock logo
CCC
Clarivate
0.00
N/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.75
Moderate Buy$6.80113.84% Upside

Current Analyst Ratings Breakdown

Latest RSW, SOPH, SCT, and CCC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2025
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.00
(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Clarivate Plc stock logo
CCC
Clarivate
$974.34M0.01$0.00 per share29.97$4.43 per share0.00
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$67.17M3.16N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Clarivate Plc stock logo
CCC
Clarivate
-$210.98M$0.35N/A0.03N/A-18.75%7.92%3.39%N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$78.98M-$1.00N/AN/AN/A-110.71%-55.06%-38.33%N/A

Latest RSW, SOPH, SCT, and CCC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.21-$0.26-$0.05-$0.26$16.76 million$17.78 million
3/4/2025Q4 2024
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.23-$0.23N/A-$0.23$17.71 million$17.73 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Clarivate Plc stock logo
CCC
Clarivate
N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Clarivate Plc stock logo
CCC
Clarivate
0.81
1.42
1.42
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
0.12
3.80
3.59

Institutional Ownership

CompanyInstitutional Ownership
Clarivate Plc stock logo
CCC
Clarivate
42.83%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%

Insider Ownership

CompanyInsider Ownership
Clarivate Plc stock logo
CCC
Clarivate
2.32%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
CompanyEmployeesShares OutstandingFree FloatOptionable
Clarivate Plc stock logo
CCC
Clarivate
4,090605.96 millionN/ANot Optionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
52066.69 million62.19 millionNot Optionable

Recent News About These Companies

Supreme Court: IVF mixup baby to remain with birth parents
The Sophia Case: When Parenthood Isn’t Just About Genetics
Sophia Genetics, Precision for Medicine enter strategic partnership
Morgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)
SOPHiA GENETICS (SOPH) Gets a Buy from BTIG

New MarketBeat Followers Over Time

Media Sentiment Over Time

Clarivate stock logo

Clarivate NYSE:CCC

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

SOPHiA GENETICS stock logo

SOPHiA GENETICS NASDAQ:SOPH

$3.18 +0.25 (+8.53%)
Closing price 05/12/2025 03:55 PM Eastern
Extended Trading
$3.22 +0.04 (+1.38%)
As of 06:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.